Mettl14-mediated m6a modification of neat1_2 releases YBX1 from paraspeckles to exacerbate
By Juan Du, Zi'ang Cheng, Yu Zhang, Yaqi Cong, Donghua Guo, Yi Zhou, Jing Huang
Originally at onlinelibrary.wiley.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
This preclinical study identifies a molecular pathway (METTL14-m6A-NEAT1_2-YBX1) that drives inflammatory bone loss in periodontitis, offering potential targets for future host-modulation therapies that could affect specialists and researchers managing refractory cases.
Key points
- Journal of Clinical Periodontology, Vol. 53, Issue 10, pp. 1621–1634 (October 2026).
- METTL14-mediated m6A modification of NEAT1_2 frees YBX1 from paraspeckles, amplifying inflammatory signaling in periodontal tissues.
- Findings are based on cell-culture and animal models; no human therapeutic or diagnostic application is reported.
Who should care
Read the original on Journal of Clinical Periodontology
Full reporting and any paywall content live on onlinelibrary.wiley.com. We summarize and score; we do not republish.
Related
- ·Research
Potential impact of persistent hyperglycemia on platelet-rich fibrin mediated regeneration
- ·Business
DSOs target de novos for growth: 5 updates
- ·Research
Ten-year clinical experience and laboratory validation of the modified tube technique for
- ·Research
Fluoridation and the risk of multiple amalgam or composite resin restorations for privately